These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27087898)

  • 1. Effects of Cyclo-His-Pro-enriched yeast hydrolysate on blood glucose levels and lipid metabolism in obese diabetic ob/ob mice.
    Jung EY; Hong YH; Park C; Suh HJ
    Nutr Res Pract; 2016 Apr; 10(2):154-60. PubMed ID: 27087898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclo (his-pro) plus zinc on glucose metabolism in genetically diabetic obese mice.
    Hwang IK; Go VL; Harris DM; Yip I; Kang KW; Song MK
    Diabetes Obes Metab; 2003 Sep; 5(5):317-24. PubMed ID: 12940869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of yeast hydrolysate on hepatic lipid metabolism in high-fat-diet-induced obese mice: yeast hydrolysate suppresses body fat accumulation by attenuating fatty acid synthesis.
    Jung EY; Hong YH; Kim JH; Park Y; Bae SH; Chang UJ; Suh HJ
    Ann Nutr Metab; 2012; 61(2):89-94. PubMed ID: 22889874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Yeast Hydrolysate Enriched in Cyclo-His-Pro (CHP) by Enzymatic Hydrolysis and Evaluation of Its Functionality.
    Lee HJ; Son HS; Park C; Suh HJ
    Prev Nutr Food Sci; 2015 Dec; 20(4):284-91. PubMed ID: 26770916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose tolerance and antioxidant activity of spent brewer's yeast hydrolysate with a high content of Cyclo-His-Pro (CHP).
    Jung EY; Lee HS; Choi JW; Ra KS; Kim MR; Suh HJ
    J Food Sci; 2011 Mar; 76(2):C272-8. PubMed ID: 21535746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice.
    O'Harte FP; Franklin ZJ; Irwin N
    Diabetes Obes Metab; 2014 Dec; 16(12):1214-22. PubMed ID: 25060150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Wyse BM; Gilchrist BJ
    Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [D-LEU-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice.
    Grasso P; Rozhavskaya-Arena M; Leinung MC; Lee DW
    Regul Pept; 2001 Sep; 101(1-3):123-9. PubMed ID: 11495687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
    Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a novel biphenyl compound, VMNS2e on ob/ob mice.
    Kurundkar SB; Sachan N; Kodam KM; Kulkarni VM; Bodhankar SL; Ghole VS
    Eur J Pharmacol; 2011 Jan; 650(1):472-8. PubMed ID: 20950599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component.
    Attele AS; Zhou YP; Xie JT; Wu JA; Zhang L; Dey L; Pugh W; Rue PA; Polonsky KS; Yuan CS
    Diabetes; 2002 Jun; 51(6):1851-8. PubMed ID: 12031973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of leptin adipose tissue lipoprotein lipase in the obese ob/ob mouse.
    Picard F; Richard D; Huang Q; Deshaies Y
    Int J Obes Relat Metab Disord; 1998 Nov; 22(11):1088-95. PubMed ID: 9822947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviation of diabetes mellitus through the restoration of β-cell function and lipid metabolism by Aloe vera (L.) Burm. f. extract in obesogenic WNIN/GR-Ob rats.
    Deora N; Sunitha MM; Satyavani M; Harishankar N; Vijayalakshmi MA; Venkataraman K; Venkateshan V
    J Ethnopharmacol; 2021 May; 272():113921. PubMed ID: 33588009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-diabetic effects of Gymnema yunnanense extract.
    Xie JT; Wang A; Mehendale S; Wu J; Aung HH; Dey L; Qiu S; Yuan CS
    Pharmacol Res; 2003 Apr; 47(4):323-9. PubMed ID: 12644390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
    Xu J; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
    Int J Biol Macromol; 2011 Nov; 49(4):657-62. PubMed ID: 21756932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
    Irwin N; McClean PL; O'Harte FP; Gault VA; Harriott P; Flatt PR
    Diabetologia; 2007 Jul; 50(7):1532-40. PubMed ID: 17486314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Dose Yeast Hydrolysate in Treatment of Obesity and Weight Loss.
    Jung EY; Lee JW; Hong YH; Chang UJ; Suh HJ
    Prev Nutr Food Sci; 2017 Mar; 22(1):45-49. PubMed ID: 28401087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression in pancreatic tissues of streptozocin-induced diabetic rats and genetically-diabetic mice in response to hypoglycemic dipeptide cyclo (His-Pro) treatment.
    Choi SA; Suh HJ; Yun JW; Choi JW
    Mol Biol Rep; 2012 Sep; 39(9):8821-35. PubMed ID: 22707198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in pancreatic protein expression in STZ-induced diabetic rats and genetically diabetic mice in response to treatment with hypoglycemic dipeptide Cyclo (His-Pro).
    Park SW; Choi SA; Yun JW; Choi JW
    Cell Physiol Biochem; 2012; 29(3-4):603-16. PubMed ID: 22616141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.